Comparation of robotic-assisted surgery and laparoscopic‑assisted surgery in children with Hirschsprung's disease: a single-centered retrospective study.
Enterocolitis
Hirschsprung’s disease
Laparoscopic-assisted surgery
Robotic-assisted surgery
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
26 Sep 2023
26 Sep 2023
Historique:
received:
11
05
2023
accepted:
25
08
2023
medline:
22
11
2023
pubmed:
27
9
2023
entrez:
26
9
2023
Statut:
epublish
Résumé
There are few studies comparing robotic-assisted surgery (RAS) and laparoscopic-assisted surgery (LAS) in Hirschsprung's disease (HSCR). This study aimed to compare intraoperative and postoperative outcomes between RAS and LAS performed during the same period. All consecutive 75 patients with pathologically diagnosed as HSCR who underwent Swenson pull-through surgery from April 2020 to Nov 2022, were included. Patients were divided into RAS group and LAS group and a retrospective analysis was performed based on clinical indexes and prognosis. A total of 75 patients were included, among which, 31 patients received RAS and 44 received LAS. The RAS and LAS groups had similar ages, sex, weight, postoperative hospital stays, and fasting times. Compared with LAS, blood loss (p = 0.002) and the incidence of Hirschsprung-associated enterocolitis (p = 0.046) were significantly lower in the RAS group. The first onset of Hirschsprung-associated enterocolitis in patients younger than 3 months occurred significantly earlier (p = 0.043). Two patients experienced anastomotic leakage in the LAS group and one patient experienced incisional hernia in the RAS group. The cost of RAS was significantly higher than that of LAS (p < 0.0001). RAS is a safe and effective alternative for HSCR children, and a delaying primary surgery until later in infancy (> 3 months) may improve outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
There are few studies comparing robotic-assisted surgery (RAS) and laparoscopic-assisted surgery (LAS) in Hirschsprung's disease (HSCR). This study aimed to compare intraoperative and postoperative outcomes between RAS and LAS performed during the same period.
METHODS
METHODS
All consecutive 75 patients with pathologically diagnosed as HSCR who underwent Swenson pull-through surgery from April 2020 to Nov 2022, were included. Patients were divided into RAS group and LAS group and a retrospective analysis was performed based on clinical indexes and prognosis.
RESULTS
RESULTS
A total of 75 patients were included, among which, 31 patients received RAS and 44 received LAS. The RAS and LAS groups had similar ages, sex, weight, postoperative hospital stays, and fasting times. Compared with LAS, blood loss (p = 0.002) and the incidence of Hirschsprung-associated enterocolitis (p = 0.046) were significantly lower in the RAS group. The first onset of Hirschsprung-associated enterocolitis in patients younger than 3 months occurred significantly earlier (p = 0.043). Two patients experienced anastomotic leakage in the LAS group and one patient experienced incisional hernia in the RAS group. The cost of RAS was significantly higher than that of LAS (p < 0.0001).
CONCLUSIONS
CONCLUSIONS
RAS is a safe and effective alternative for HSCR children, and a delaying primary surgery until later in infancy (> 3 months) may improve outcomes.
Identifiants
pubmed: 37752449
doi: 10.1186/s12893-023-02169-2
pii: 10.1186/s12893-023-02169-2
pmc: PMC10521487
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
294Subventions
Organisme : Health Science and Technology Plan of Zhejiang Province
ID : 2022RC201
Organisme : Zhejiang Provincial Natural Science Foundation Project
ID : LY20H030007
Organisme : Clinical Medical Research of Minimally Invasive Diagnosis and Treatment of Abdominal Organs in Zhejiang Province
ID : 01492-02
Organisme : Science and Technology Program of Zhejiang Province
ID : 2023C03029
Informations de copyright
© 2023. The Author(s).
Références
J Laparoendosc Adv Surg Tech A. 2019 Dec;29(12):1605-1608
pubmed: 31613695
J Pediatr Surg. 2017 Jul;52(7):1102-1107
pubmed: 28185631
J Pediatr Surg. 2014 Aug;49(8):1242-51
pubmed: 25092084
PLoS One. 2015 Apr 24;10(4):e0124172
pubmed: 25909773
Int J Colorectal Dis. 2019 Feb;34(2):255-259
pubmed: 30368570
BMC Pediatr. 2022 Nov 10;22(1):654
pubmed: 36357849
J Pediatr Surg. 2013 Jan;48(1):111-7
pubmed: 23331802
J Laparoendosc Adv Surg Tech A. 2017 May;27(5):546-549
pubmed: 28099057
Pediatr Surg Int. 2017 May;33(5):517-521
pubmed: 28154902
Macromol Biosci. 2015 May;15(5):712-8
pubmed: 25644515
Arch Dis Child. 1960 Feb;35:38-9
pubmed: 13818513
Am Surg. 2011 Jul;77(7):937-41
pubmed: 21944363
Pediatr Surg Int. 2022 Jan;38(1):51-57
pubmed: 34557957
Surgery. 1948 Aug;24(2):212-20
pubmed: 18872852
Eur J Immunol. 2015 Mar;45(3):807-17
pubmed: 25487064
J Robot Surg. 2022 Apr;16(2):301-305
pubmed: 33843006
J Pediatr Surg. 2022 Apr;57(4):719-725
pubmed: 34330420
J Pediatr Surg. 2010 Mar;45(3):475-82
pubmed: 20223308
Pediatr Surg Int. 2020 Feb;36(2):209-218
pubmed: 31659436
Arch Dis Child. 1964 Apr;39:116-24
pubmed: 14131949
J Pediatr Surg. 2008 Jun;43(6):1115-23
pubmed: 18558193
J Pediatr Surg. 1995 Jul;30(7):1017-21; discussion 1021-2
pubmed: 7472924
Neurogastroenterol Motil. 2012 Sep;24(9):874-e400
pubmed: 22626027